Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,761
archived clinical trials in
Osteoporosis

A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Duncansville, PA
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Erie, PA
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Erie, PA
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Feasterville, PA
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Feasterville, PA
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Philadelphia, PA
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Anderson, SC
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Memphis, TN
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
mi
from
Selmer, TN
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
mi
from
Selmer, TN
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Bedford, TX
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Bedford, TX
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Bryan, TX
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Bryan, TX
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Dallas, TX
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Houston, TX
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Temple, TX
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Temple, TX
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Richmond, VA
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated:  7/31/2015
Clinical Research Facility
mi
from
Seattle, WA
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
Status: Enrolling
Updated:  8/10/2015
University of Pittsburgh Medical Center (GCRC)
mi
from
Pittsburgh, PA
The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
Status: Enrolling
Updated: 8/10/2015
University of Pittsburgh Medical Center (GCRC)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
Cyclical vs Daily Continuous PTH in Combination With Alendronate vs Alendronate Alone
Status: Enrolling
Updated:  8/17/2015
Helen Hayes Hospital, Clinical Research Center
mi
from
West Haverstraw, NY
Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
Cyclical vs Daily Continuous PTH in Combination With Alendronate vs Alendronate Alone
Status: Enrolling
Updated: 8/17/2015
Helen Hayes Hospital, Clinical Research Center
mi
from
West Haverstraw, NY
Click here to add this to my saved trials
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
New Port Richey, FL
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Orlando, FL
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
New York, NY
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Durham, NC
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Fargo, ND
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated:  9/3/2015
mi
from
Toronto,
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture
Status: Enrolling
Updated: 9/3/2015
mi
from
Toronto,
Click here to add this to my saved trials
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  9/11/2015
Clinical Research Facility
mi
from
Lakewood, CO
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 9/11/2015
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  9/11/2015
Clinical Research Facility
mi
from
Gainesville, GA
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 9/11/2015
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  9/11/2015
Clinical Research Facility
mi
from
Detroit, MI
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 9/11/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  9/11/2015
Clinical Research Facility
mi
from
Omaha, NE
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 9/11/2015
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  9/11/2015
mi
from
Vancouver,
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 9/11/2015
mi
from
Vancouver,
Click here to add this to my saved trials
Musculoskeletal Effects of Bicarbonate
Musculoskeletal Benefits of Bicarbonate in Older Adults - A Dose-Finding Trial
Status: Enrolling
Updated:  9/18/2015
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Musculoskeletal Effects of Bicarbonate
Musculoskeletal Benefits of Bicarbonate in Older Adults - A Dose-Finding Trial
Status: Enrolling
Updated: 9/18/2015
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
Soy, Bone and Health in College Females
Influence of Soy on Bone Turnover and Body Composition in College Females
Status: Enrolling
Updated:  9/23/2015
University of Georgia
mi
from
Athens, GA
Soy, Bone and Health in College Females
Influence of Soy on Bone Turnover and Body Composition in College Females
Status: Enrolling
Updated: 9/23/2015
University of Georgia
mi
from
Athens, GA
Click here to add this to my saved trials
Bone Mineral Density in Women With Major Depression
Bone Mineral Density in Patients With Major Depression With Melancholic and Atypical Features: Relation to Stress-System Neurohormonal Function
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Bone Mineral Density in Women With Major Depression
Bone Mineral Density in Patients With Major Depression With Melancholic and Atypical Features: Relation to Stress-System Neurohormonal Function
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Vitamin D Administration in the Nursing Home
Intermittent Vitamin D Administration in the Nursing Home: Impact on Vitamin D Status, Falls, Bone Turnover and Bone Density
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin
mi
from
Madison, WI
Vitamin D Administration in the Nursing Home
Intermittent Vitamin D Administration in the Nursing Home: Impact on Vitamin D Status, Falls, Bone Turnover and Bone Density
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
La Jolla, CA
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Augusta, GA
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Woodbury, MN
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Woodbury, MN
Click here to add this to my saved trials
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Bronx, NY
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Hopwood, PA
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Hopwood, PA
Click here to add this to my saved trials
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Madison, WI
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated:  10/1/2015
mi
from
Ponce,
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
A Randomized Double-blind Study to Determine the Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once-monthly Boniva (Ibandronate) Versus Placebo in the Treatment of Post-menopausal Osteoporosis
Status: Enrolling
Updated: 10/1/2015
mi
from
Ponce,
Click here to add this to my saved trials
Bone Microarchitecture in Women With and Without Fracture
Bone Microarchitecture in Women With and Without Fracture
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin Hospitals and Clinics
mi
from
Madison, WI
Bone Microarchitecture in Women With and Without Fracture
Bone Microarchitecture in Women With and Without Fracture
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin Hospitals and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Bone Microarchitecture in Women With and Without Fracture
Bone Microarchitecture in Women With and Without Fracture
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin Osteoporosis Clinical and Research Program
mi
from
Madison, WI
Bone Microarchitecture in Women With and Without Fracture
Bone Microarchitecture in Women With and Without Fracture
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin Osteoporosis Clinical and Research Program
mi
from
Madison, WI
Click here to add this to my saved trials
Does Gender Play a Role in Bone-mineral Density Measurement Precision?
Does Gender Play a Role in Bone-mineral Density Measurement Precision?
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin Osteoporosis Clinical Center and Research Program
mi
from
Madison, WI
Does Gender Play a Role in Bone-mineral Density Measurement Precision?
Does Gender Play a Role in Bone-mineral Density Measurement Precision?
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin Osteoporosis Clinical Center and Research Program
mi
from
Madison, WI
Click here to add this to my saved trials
The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin
The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin
Status: Enrolling
Updated:  10/13/2015
Staten Island University Hospital
mi
from
Staten Island, NY
The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin
The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin
Status: Enrolling
Updated: 10/13/2015
Staten Island University Hospital
mi
from
Staten Island, NY
Click here to add this to my saved trials
Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Effect of HIV Infection and HAART on Bone Homeostasis
Status: Enrolling
Updated:  10/15/2015
Grady Infectious Diseases Program Clinic
mi
from
Atlanta, GA
Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Effect of HIV Infection and HAART on Bone Homeostasis
Status: Enrolling
Updated: 10/15/2015
Grady Infectious Diseases Program Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Effect of HIV Infection and HAART on Bone Homeostasis
Status: Enrolling
Updated:  10/15/2015
Grady Infectious Diseases Program Clinic
mi
from
Atlanta, GA
Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Effect of HIV Infection and HAART on Bone Homeostasis
Status: Enrolling
Updated: 10/15/2015
Grady Infectious Diseases Program Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Exercise for Physical Health in Men With Prostate Cancer
Exercise for Physical Health in Men With Prostate Cancer
Status: Enrolling
Updated:  10/20/2015
OHSU School of Nursing
mi
from
Portland, OR
Exercise for Physical Health in Men With Prostate Cancer
Exercise for Physical Health in Men With Prostate Cancer
Status: Enrolling
Updated: 10/20/2015
OHSU School of Nursing
mi
from
Portland, OR
Click here to add this to my saved trials
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Status: Enrolling
Updated:  11/10/2015
Capstone Clinical Trials
mi
from
Birmingham, AL
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Status: Enrolling
Updated: 11/10/2015
Capstone Clinical Trials
mi
from
Birmingham, AL
Click here to add this to my saved trials
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Status: Enrolling
Updated:  11/10/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Status: Enrolling
Updated: 11/10/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Status: Enrolling
Updated:  11/10/2015
Rheumatology Associates Of North Alabama, P.C.
mi
from
Huntsville, AL
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Status: Enrolling
Updated: 11/10/2015
Rheumatology Associates Of North Alabama, P.C.
mi
from
Huntsville, AL
Click here to add this to my saved trials